Stockreport

Spring Bank Submits IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors

SPRING BANK PHARMACEUTICALS  (SBPH) 
Last spring bank pharmaceuticals earnings: 11/7 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.springbankpharm.com/investor-overview
PDF HOPKINTON, Mass., July 01, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel thera [Read more]